Precision Medicine's Surge And Its Impact On The Growing Pharmacogenomics Market Size & Growth Insights: Emerging Trends and Future Projections 2025-2034

The Pharmacogenomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Pharmacogenomics Market Size and Projected Growth Rate?
In recent times, the size of the pharmacogenomics market has seen a rapid surge. From 2024 to 2025, it is expected to rise from $8.94 billion to $9.92 billion, marking a compound annual growth rate (CAGR) of 10.9%. Factors such as robust economic development in evolving markets, an intensified emphasis on personalized medicine, augmentation of advanced healthcare infrastructure and heightened healthcare spending contributed to the growth in the historic period.

The pharmacogenomics market is poised for substantial growth in the coming years, and it's projected that it will surge to $14.81 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. This anticipated growth during the forecast period is largely due to factors such as the rising aging population, the prevalence of chronic diseases, population growth as well as increased demand for cancer therapies. The forecast period will be significant for new trends including the introduction of genome editing solutions for more comprehensive analysis of advanced treatments, the application of artificial intelligence (AI) in genomics for genetic data analysis, progression in metagenomics, and strategic alliances and collaborations among market participants. Additionally, the emergence of three-dimensional (3D) genomics for studying gene influence on expression and function, innovative product launches with focus on infectious diseases and gene editing, and the development of psychotropic pharmacogenomics test for better decision-making are also expected to shape the market.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7072

What Are the Major Segments in the Pharmacogenomics Market?
The pharmacogenomics market covered in this report is segmented -

1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies
2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications
3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

Subsegments:
1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing
2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR
3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis
4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)
5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays
6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp

What Are The Driving Pharmacogenomics Market Evolution?
The escalating need for precision medicine is fueling the growth of the pharmacogenomics market. Precision medicine represents healthcare personalization, leading to medical decisions, treatments, methodologies, or products being specifically designed for a particular group of patients, rather than the traditional universal drug approach. The demand has increased as precision medicine has progressed most in the field of oncology and beyond it, including late-stage ailments like rare and genetic diseases. The fundamental goal of precision medicine is to combine genetic and environmental factors about specific diseases and their treatment responses. For example, an article posted on Linchpinseo in March 2022 highlighted that the rise in investment for precision medicine from leading pharma companies is expected to grow by a third within five years. Moreover, in the USA, precision medicine offers individualized treatment for 30 million people suffering from type 2 diabetes, promising to reshape existing treatment protocols. Consequently, the surging need for precision medicine will further propel the pharmacogenomics market.

Which Firms Dominate The Pharmacogenomics Market Segments?
Major companies operating in the pharmacogenomics market include Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos

What Trends Are Driving Growth in The Pharmacogenomics Market?
The surge in technological progress is a leading trend gaining traction in the pharmacogenomics market. Drug manufacturers are exploring diverse approaches to pharmacogenomics analysis to present cost-efficient solutions for identifying recognized polymorphisms and discovering new variants. Take, for instance, the US-centric medical lab firm Invitae rolled out its broader Pharmacogenomics Panel in May 2022. The extended Invitae Pharmacogenomics (PGx) Panel, inclusive of the Mental Health Panel, delivers insights into genetic reactions to medications across various disciplines such as primary care, cardiology, and oncology. Given that nearly a quarter of patients experience unusual drug responses due to their genetics, it is predicted that PGx testing will become a routine procedure. For smooth incorporation into healthcare, enhanced support is necessary for providers to comprehend and implement PGx testing in their clinic settings.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Which Is The Largest Region In The Pharmacogenomics Market?
North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pharmacogenomics Market?
2. What is the CAGR expected in the Pharmacogenomics Market?
3. What Are the Key Innovations Transforming the Pharmacogenomics Industry?
4. Which Region Is Leading the Pharmacogenomics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.